These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11317876

  • 1. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection.
    Pokorski RJ.
    J Insur Med; 2001; 33(1):12-36. PubMed ID: 11317876
    [Abstract] [Full Text] [Related]

  • 2. Long-term insured lives morbidity and mortality risk associated with chronic hepatitis C virus infection.
    Pokorski RJ.
    J Insur Med; 2000; 32(4):226-48. PubMed ID: 16104370
    [Abstract] [Full Text] [Related]

  • 3. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Angel Casado M, Fosbrook L, Esteban R.
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [Abstract] [Full Text] [Related]

  • 4. Natural history of hepatitis C.
    Seeff LB.
    Hepatology; 1997 Sep; 26(3 Suppl 1):21S-28S. PubMed ID: 9305659
    [Abstract] [Full Text] [Related]

  • 5. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N, Rizzetto M.
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [Abstract] [Full Text] [Related]

  • 6. Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.
    Thein HH, Yi Q, Heathcote EJ, Krahn MD.
    J Viral Hepat; 2009 Nov; 16(11):802-13. PubMed ID: 19413692
    [Abstract] [Full Text] [Related]

  • 7. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM, Wilson ML.
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [Abstract] [Full Text] [Related]

  • 8. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
    Tanaka J, Kumada H, Ikeda K, Chayama K, Mizui M, Hino K, Katayama K, Kumagai J, Komiya Y, Miyakawa Y, Yoshizawa H.
    J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
    [Abstract] [Full Text] [Related]

  • 9. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL, Albright JE, Cook SF, Rosenberg DM.
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
    Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J.
    Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
    [Abstract] [Full Text] [Related]

  • 11. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
    Duberg AS, Törner A, Davidsdóttir L, Aleman S, Blaxhult A, Svensson A, Hultcrantz R, Bäck E, Ekdahl K.
    J Viral Hepat; 2008 Jul; 15(7):538-50. PubMed ID: 18397223
    [Abstract] [Full Text] [Related]

  • 12. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [Abstract] [Full Text] [Related]

  • 13. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M, Icona Foundation Study Group.
    Clin Infect Dis; 2009 Aug 15; 49(4):612-22. PubMed ID: 19591597
    [Abstract] [Full Text] [Related]

  • 14. Estimating progression to cirrhosis in chronic hepatitis C virus infection.
    Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM.
    Hepatology; 2001 Oct 15; 34(4 Pt 1):809-16. PubMed ID: 11584380
    [Abstract] [Full Text] [Related]

  • 15. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
    Vallet-Pichard A, Pol S.
    J Hepatol; 2006 Oct 15; 44(1 Suppl):S28-34. PubMed ID: 16343684
    [Abstract] [Full Text] [Related]

  • 16. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2009 Apr 15; 24(4):581-7. PubMed ID: 19032460
    [Abstract] [Full Text] [Related]

  • 17. Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990.
    Krahn M, Wong JB, Heathcote J, Scully L, Seeff L.
    Med Decis Making; 2004 Apr 15; 24(1):20-9. PubMed ID: 15005951
    [Abstract] [Full Text] [Related]

  • 18. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V, Berenguer M, Rayón JM, Carrasco D, Berenguer J.
    Am J Gastroenterol; 2002 Sep 15; 97(9):2408-14. PubMed ID: 12358265
    [Abstract] [Full Text] [Related]

  • 19. The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.
    Sheerin IG, Green FT, Sellman JD.
    Drug Alcohol Rev; 2003 Jun 15; 22(2):159-67. PubMed ID: 12850902
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
    Arao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y, Ishikawa T, Tagaya T, Yamanouchi K, Ichimiya H, Sameshima Y, Kakumu S.
    J Gastroenterol; 2003 Jun 15; 38(4):355-60. PubMed ID: 12743775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.